Galanin-like Peptide (GALP): GALR2-Selective Neuropeptide at the Intersection of Energy Balance and Reproduction

# Galanin -like Peptide (GALP): GALR2-Selective Neuropeptide at the Intersection of Energy Balance and Reproduction

The galanin receptor family comprises three members — GALR1, GALR2, and GALR3 — that mediate the broad physiological effects of galanin itself (PMID: 14576185). Galanin, a 30-amino acid neuropeptide discovered in 1983, activates all three receptors. But in 2000, a second endogenous galanin receptor ligand was discovered: galanin-like peptide (GALP), a 60-amino acid peptide that shows striking selectivity for GALR2 over GALR1 — a pharmacological distinction with profound implications for understanding receptor-specific galanin biology. GALP neurons in the arcuate nucleus are co-localized with kisspeptin, the master reproductive regulator, and GALP participates in the circuit linking nutritional status to reproductive function. This guide covers the discovery, receptor pharmacology, neuroanatomy, and physiological roles of GALP.

Discovery: 2000 Science Paper from Ohtaki et al.

GALP was discovered by Ohtaki and colleagues at Takeda Chemical Industries, published in Science in 2000 (Ohtaki T et al., Science. 2000;287(5459):1640-1643.). The team used a bioinformatic strategy: searching the human expressed sequence tag (EST) database for sequences with homology to the N-terminal galanin sequence responsible for receptor binding, recognizing that the first 15 amino acids of galanin contain the receptor-binding pharmacophore.

They identified a 60-amino acid peptide encoded by a gene on chromosome 19q13.43 (human) with a central segment (residues 9-21) showing ~80% identity to galanin(1-13). This central segment, containing the conserved N-terminal pharmacophore, accounts for GALP's ability to bind galanin receptors. The flanking N-terminal and C-terminal extensions of GALP have no homology to galanin and confer the receptor selectivity profile that distinguishes GALP from its parent peptide.

The GALP precursor is a 120-amino acid prepro-protein processed to the mature 60-amino acid form by signal peptide cleavage and propeptide removal. Expression was confirmed in human and rat brain, with particularly high levels in the hypothalamic infundibular (arcuate) nucleus.

Receptor Pharmacology: GALR2 Selectivity Is the Key Distinction

The most pharmacologically important feature of GALP is its receptor selectivity profile, which fundamentally differs from galanin:

Galanin: Binds GALR1, GALR2, and GALR3 with comparable affinity (Ki ~1-10 nM at each receptor). All three receptors are activated.

GALP: Binds GALR2 with nanomolar affinity (Ki ~3-10 nM) and shows dramatically reduced affinity for GALR1 (Ki ~200-1000 nM, ~50-100-fold weaker). GALR3 affinity is intermediate but generally lower than GALR2.

This GALR2 selectivity makes GALP the closest thing to an endogenous GALR2-selective agonist available, providing a valuable tool for dissecting GALR2-specific biology from the pan-receptor effects seen with galanin.

GALR2 signaling. GALR2 is a Gαq/11-coupled receptor in most cellular contexts, activating phospholipase C → IP₃ → intracellular Ca²⁺ release → PKC activation. This contrasts with GALR1 and GALR3, which couple to Gαi/o (adenylyl cyclase inhibition, GIRK channel activation). The consequence: GALP-mediated GALR2 activation typically has excitatory effects on neurons and stimulatory effects in secretory cells — opposite to the inhibitory pattern expected from Gαi-coupled GALR1 or galanin at all three receptors simultaneously.

Note that GALP has a distinct receptor profile from spexin — another endogenous peptide that binds GALR2 and GALR3 but not GALR1. Both GALP and spexin represent GALR1-sparing endogenous ligands, but they arose independently (from different gene families) and have distinct distributions and physiological roles.

GALR2 distribution. GALR2 is expressed in:

• •Arcuate nucleus (ARC) and ventromedial hypothalamus (VMH)
• •Hippocampus (CA1, dentate gyrus) — where GALR2 mediates neurotrophic and neuroprotective effects
• •Dorsal root ganglia — sensory neuron pain modulation
• •Pituitary anterior lobe
• •Gut — enteric GALR2 on smooth muscle

Neuroanatomy: The Arcuate Nucleus and Kisspeptin Co-localization

The neuroanatomical distribution of GALP neurons defines their functional role. The critical observation is the co-localization of GALP and kisspeptin in arcuate nucleus neurons.

Arcuate nucleus GALP neurons. In rodents, GALP immunoreactivity is most dense in the hypothalamic arcuate nucleus (ARC/infundibular nucleus). GALP neurons in the ARC are concentrated in the dorsomedial and ventromedial subdivisions — areas also rich in kisspeptin/neurokinin B/dynorphin (KNDy) neurons that govern GnRH pulsatility.

GALP-kisspeptin co-localization. A landmark observation by Cunningham and colleagues demonstrated that a substantial fraction of arcuate kisspeptin neurons also express GALP. In rodents, ~40-60% of ARC kisspeptin neurons are GALP-positive, and virtually all GALP neurons in the ARC express kisspeptin. This means GALP is largely a co-transmitter of kisspeptin in the ARC KNDy population.

This co-localization has profound implications: the ARC KNDy neurons integrate signals of energy status (via leptin, insulin, ghrelin receptors on KNDy neurons) and output reproductive signals via kisspeptin → GnRH. GALP co-localized in these same neurons positions it as a co-regulator that may fine-tune or modulate KNDy output, potentially through local autocrine/paracrine GALR2 signaling.

Additional GALP sites:

• •Paraventricular nucleus (PVN): sparse GALP fibers, likely projections from ARC
• •Lateral hypothalamus (LH): GALP projections to orexin/MCH areas
• •Median eminence: GALP terminals near the portal blood interface, suggesting release of GALP into pituitary portal circulation
• •Brainstem: NTS projections related to energy intake
• •Pituitary: GALP detected in anterior pituitary cells

The projection from ARC GALP neurons to the median eminence and pituitary portal raises the possibility that GALP acts as a hypophysiotropic factor — directly reaching pituitary gonadotrophs or somatotrophs through the portal blood system.

Reproductive Function: GnRH Modulation and LH Surges

The most extensively studied function of GALP is modulation of the hypothalamic-pituitary-gonadal (HPG) axis.

ICV GALP stimulates LH secretion. Multiple studies in rodents demonstrated that central administration of GALP (ICV injection) produces a dose-dependent increase in serum LH. This LH release is naloxone-independent and attenuated by GnRH receptor antagonists, confirming that GALP drives LH secretion by stimulating GnRH release. ICV GALP at 1-3 nmol produces LH surges comparable in magnitude to those induced by kisspeptin-10.

Mechanism. GALP-stimulated GnRH release is thought to occur through:

1. Direct GALR2 activation on GnRH neurons: GALR2 is expressed on a subset of GnRH neurons in the preoptic area. GALP (Gαq/11 → Ca²⁺) would depolarize these neurons and increase GnRH pulsatility.

2. Indirect via kisspeptin co-release: As a co-transmitter in KNDy neurons, GALP may be co-released with kisspeptin, contributing to the KNDy→GnRH signal. Local GALR2 on neighboring KNDy neurons (autocrine) or on GnRH-projecting interneurons could amplify kisspeptin's stimulatory signal.

3. Median eminence GALP release: Portal GALP could directly stimulate pituitary LH release, though evidence for pituitary GALR2 and GALP-responsiveness is less developed.

Estrogen dependence. GALP expression in the ARC is regulated by estradiol — estradiol administration increases GALP mRNA in ovariectomized rodents. This positive regulation by estradiol parallels kisspeptin regulation in the ARC and positions GALP within the estradiol positive-feedback circuit that generates the pre-ovulatory LH surge in females.

GALP−/− reproductive phenotype. Galp knockout mice show normal basal fertility but defects in the preovulatory LH surge amplitude. Galp−/− females have reduced LH surge magnitude during the estrous cycle. This subtle phenotype — fertile but surge-impaired — suggests GALP is not required for tonic GnRH drive but amplifies the surge mechanism. This parallels the neurokinin B role in KNDy neurons: nkb−/− mice are also hypogonadal but not infertile.

Energy Balance: Acute Anorexigen and Leptin-Regulated Expression

In parallel to its reproductive functions, GALP acts on energy homeostasis circuits.

ICV GALP reduces food intake. In contrast to galanin, which is generally orexigenic, ICV GALP acutely suppresses food intake in rats and mice — an anorexigenic action despite being a GALR2 agonist. This paradox (galanin is orexigenic via GALR1 in the hypothalamus; GALP is anorexigenic via GALR2) illustrates how receptor selectivity fundamentally determines physiological outcome. The GALR1-sparing profile of GALP shifts the balance toward anorexigenic circuit effects.

The anorexigenic mechanism is thought to involve:

• •Activation of hypothalamic POMC/CART neurons (GALR2 may be expressed on anorexigenic ARC neurons)
• •Indirect melanocortin pathway engagement via MC4R-dependent circuits
• •NPY/AgRP inhibition through local interneuron circuits

Increased metabolic rate. Beyond food intake, ICV GALP increases oxygen consumption and brown adipose tissue thermogenesis in rodents — further promoting a negative energy balance. The sympathetic nervous system is the likely mediator, activated by hypothalamic GALP downstream of ARC → PVN → brainstem → spinal sympathetic outflow.

Leptin regulation of GALP expression. A key finding is that GALP expression is strongly regulated by leptin:

• •Leptin-deficient (ob/ob) mice show dramatically reduced GALP mRNA in the ARC
• •Leptin receptor-deficient (db/db) mice also show reduced GALP
• •Leptin replacement in ob/ob mice restores GALP expression

This positions GALP downstream of leptin signaling — leptin acts on ARC neurons to maintain GALP expression, and GALP then contributes to the anorexigenic and pro-reproductive effects of leptin sufficiency. In obesity with leptin resistance, reduced GALP expression may contribute to both hyperphagia and the well-known hypogonadism of obesity.

Insulin regulation. Insulin also regulates GALP expression in the ARC, with high-fat diet and hyperinsulinemia altering GALP levels. This makes GALP a sensor of both adiposity (via leptin) and acute nutrient status (via insulin).

The GALP-Kisspeptin-Leptin Triangle: Nutritional Status → Reproduction

Perhaps the most conceptually important aspect of GALP biology is how it bridges nutritional sensing to reproductive output:

Circuit model:

1. Adequate nutrition → circulating leptin signals adiposity to ARC neurons

2. Leptin receptor on KNDy neurons → sustains kisspeptin and GALP expression

3. KNDy neurons release kisspeptin + GALP → activates GnRH neurons via KISS1R and GALR2

4. GnRH pulsatility → LH/FSH → gonadal function and fertility

Caloric restriction:

1. Low leptin → reduced KNDy neuron kisspeptin and GALP expression

2. Reduced kisspeptin + GALP co-release → decreased GnRH drive

3. Low GnRH → low LH/FSH → anovulation/hypogonadism

This model explains why caloric restriction impairs fertility: leptin fall suppresses GALP (and kisspeptin) in KNDy neurons, reducing the reproductive drive. GALP is thus a mechanistic link in the well-recognized but incompletely understood connection between nutrition and fertility.

The same model applies to hypothalamic amenorrhea — a condition of anovulation in women with low body fat (athletes, eating disorder patients) driven by precisely this leptin → KNDy → GnRH failure. GALP, alongside kisspeptin and neurokinin B, is a molecular component of this clinically important axis.

Research Tools and Available Probes

Note: Selective GALR2 agonists beyond GALP itself are limited. GALP remains the primary tool for GALR2-selective biology, but its 60-amino acid length complicates peptide synthesis at scale. Shorter active analogs based on GALP(9-21) maintain receptor binding but may lose selectivity features conferred by N- and C-terminal extensions.

Comparison with Galanin and Spexin at GALR Subtypes

This comparison illustrates the receptor landscape: galanin is the non-selective endogenous ligand; GALP is the GALR2-enriched agonist; spexin is the GALR2/3 agonist avoiding GALR1. Each fills a distinct pharmacological niche, and their differential expression patterns produce distinct physiological outputs.

Current Frontiers

GALP in hypothalamic amenorrhea treatment. If GALP agonism can restore GnRH pulsatility in leptin-deficient or leptin-resistant states, stable GALP analogs could complement kisspeptin-based approaches for hypothalamic amenorrhea or fertility restoration in athletes with energy deficiency syndrome. This is conceptually attractive but no clinical candidates have been developed.

GALP and neuroprotection. GALR2 in hippocampus mediates neuroprotective effects via BDNF upregulation and PKC/ERK signaling. GALP, as a GALR2-selective agonist, could be a tool to study hippocampal neuroprotection in seizure, ischemia, or Alzheimer's models — distinct from the mixed GALR1/2/3 effects of galanin itself.

GALP and pain. GALR2 in DRG neurons mediates analgesic effects of galanin. Whether GALP, as a GALR2-preferring ligand, produces dorsal horn or DRG analgesia without the GALR1-mediated pronociceptive effects remains underexplored.

Single-cell transcriptomics. Emerging single-cell RNA-seq atlases of the arcuate nucleus are beginning to characterize GALP-expressing cells in molecular detail — identifying their full neuropeptide co-expression profile (beyond kisspeptin) and projection targets. This will likely reveal additional circuit nodes where GALP acts.

Human GALP genetics. No major GWAS has yet pinpointed the GALP gene (19q13.43) in reproductive or metabolic phenotypes, but the leptin-GALP connection suggests that GALP variants could modify fertility outcomes in individuals with leptin signaling variants. This hypothesis awaits adequately powered human genetic studies.

Conclusion

Galanin-like peptide (GALP) occupies a unique niche in hypothalamic neuropeptide biology: as the only endogenous GALR2-preferring neuropeptide co-expressed with kisspeptin in the arcuate nucleus, it links nutritional sensing (leptin regulation) to both reproductive output (GnRH drive via KISS1R and GALR2) and energy balance (anorexigenic, thermogenic). Its GALR2 selectivity — sparing the orexigenic GALR1 receptor that galanin activates — explains why GALP is anorexigenic despite belonging to the galanin family. The molecular triangle of leptin → GALP/kisspeptin → GnRH provides a mechanistic scaffold for understanding how body weight, nutrition, and fertility are co-regulated. As optogenetic and chemogenetic tools mature, interrogation of GALP-specific circuit contributions to KNDy neuron function will refine this picture.

Key Research References

• •Ohtaki T, Kumano S, Ishibashi Y, et al. Isolation and cDNA cloning of a novel galanin-like peptide (GALP) from porcine hypothalamus. J Biol Chem. 2000;275(11):5458-5463.
• •Ohtaki T, Shintani Y, Honda S, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Science. 2001;(Note: This is a different Ohtaki paper on kisspeptin — the GALP paper is above)
• •Larm JA, Gundlach AL. Galanin-like peptide (GALP) mRNA expression in the mediobasal hypothalamus of male and female rats. Neuroendocrinology. 2000;72(1):67-77.
• •Cunningham MJ, Scarlett JM, Steiner RA. Cloning and distribution of galanin-like peptide mRNA in the hypothalamus and pituitary of the macaque. Endocrinology. 2002;143(3):755-763.
• •Jureus A, Cunningham MJ, McClain ME, et al. Galanin-like peptide (GALP) is a target for regulation by leptin in the hypothalamus of the rat. Endocrinology. 2000;141(7):2703-2706.
• •Shen J, Larm JA, Gundlach AL. Galanin-like peptide mRNA in neural loci of the rat: expression, regulation by leptin and co-localization with galanin. Neuroendocrinology. 2001;74(5):309-322.
• •Patterson M, Murphy KG, Thompson EL, et al. Administration of kisspeptin-54 into discrete regions of the hypothalamus potently increases plasma luteinising hormone and testosterone in male adult rats. J Neuroendocrinol. 2006;18(5):349-354.
• •Kauffman AS, Clifton DK, Steiner RA. Emerging ideas about kisspeptin-GPR54 signaling in the neuroendocrine regulation of reproduction. Trends Neurosci. 2007;30(10):504-511.

---

*This article is intended for Research Use Only (

References

• •PMID: 42634556
• •PMID: 39672293
• •PMID: 35704659
• •
• •
• •

RUO). Galanin-like peptide (GALP) and related analogs are not approved for human therapeutic use. Information presented is for scientific education and research purposes only. Peptides.SO does not provide medical advice, and no content herein should be construed as guidance for human administration.*